What does CATALDO MEDICALS do?

CATALDO MEDICALS is a general practice in Olne. Private Limited, started on 13 January 2004, 1 establishment.

What is the address of CATALDO MEDICALS?

The registered office of CATALDO MEDICALS is located at Chemin du Vieux Puits 4, 4877 Olne.

Is CATALDO MEDICALS still active?

Yes. According to the CBE (29 October 2026) CATALDO MEDICALS is active, legal situation “Normale toestand”, started on 13 January 2004.

Is CATALDO MEDICALS registered on Peppol?

Yes, CATALDO MEDICALS is registered on the Peppol network with ID 0208:0862651484.

What is the enterprise number of CATALDO MEDICALS?

The enterprise number of CATALDO MEDICALS is BE0862651484.

When was CATALDO MEDICALS founded?

CATALDO MEDICALS was founded on 13 January 2004.

Who are the directors of CATALDO MEDICALS?

According to the 2025 annual accounts, the directors of CATALDO MEDICALS are: Didier CATALDO, Anne GODON.

Is CATALDO MEDICALS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 January 2004; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did CATALDO MEDICALS make in 2025?

CATALDO MEDICALS posted a profit after taxes of € 618,272 in financial year 2025.

What is the revenue of CATALDO MEDICALS?

As a small company, CATALDO MEDICALS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 554,899.

How many employees does CATALDO MEDICALS have?

According to the 2025 annual accounts, CATALDO MEDICALS has 0.2 full-time equivalents (FTE).

CATALDO MEDICALS (Private Limited) - Olne - BE0862651484

Dossier CATALDO MEDICALS, printed on 29 October 2026 from databakkes.be/en/0862651484/cataldo-medicals. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CATALDO MEDICALS from Olne, company number BE0862651484, closed financial year 2025 with a result of € 618,272 after tax. For that financial year CATALDO MEDICALS recorded a gross margin of € 554,899 and equity of € 199,688. Compared with financial year 2024, the result moved from € 518,031 to € 618,272. Profitable, and profit is growing. The buffer shrank hard: equity is 58 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What it is worth Shrank hard

€ 199,688

▼ 58% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 618,272

▲ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 243,946

▼ 21% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 630,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

0.2

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 3,148

▼ 21% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,954

▲ 82% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 11,285

▼ 12% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 152,681

▲ 23% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 492,734 Gross margin 2022: € 492,734 First fiscal year in the series	€ 579,606 Gross margin 2023: € 579,606 ▲ 18% vs 2022 (€ 492,734) Favourable step	€ 697,386 Gross margin 2024: € 697,386 ▲ 20% vs 2023 (€ 579,606) Favourable step	€ 554,899 Gross margin 2025: € 554,899 ▼ 20% vs 2024 (€ 697,386) Unfavourable step	▼ 20%
Profit after taxes	€ 369,773 Profit after taxes 2022: € 369,773 First fiscal year in the series	€ 434,843 Profit after taxes 2023: € 434,843 ▲ 18% vs 2022 (€ 369,773) Favourable step	€ 518,031 Profit after taxes 2024: € 518,031 ▲ 19% vs 2023 (€ 434,843) Favourable step	€ 618,272 Profit after taxes 2025: € 618,272 ▲ 19% vs 2024 (€ 518,031) Favourable step	▲ 19%
Equity	€ 378,182 Equity 2022: € 378,182 First fiscal year in the series	€ 437,568 Equity 2023: € 437,568 ▲ 16% vs 2022 (€ 378,182) Favourable step	€ 480,035 Equity 2024: € 480,035 ▲ 10% vs 2023 (€ 437,568) Favourable step	€ 199,688 Equity 2025: € 199,688 ▼ 58% vs 2024 (€ 480,035) Unfavourable step	▼ 58%
Total debts	€ 885,950 Total debts 2022: € 885,950 First fiscal year in the series	€ 342,814 Total debts 2023: € 342,814 ▼ 61% vs 2022 (€ 885,950) Favourable step	€ 603,413 Total debts 2024: € 603,413 ▲ 76% vs 2023 (€ 342,814) Unfavourable step	€ 467,012 Total debts 2025: € 467,012 ▼ 23% vs 2024 (€ 603,413) Favourable step	▼ 23%
Cash	€ 447,496 Cash 2022: € 447,496 First fiscal year in the series	€ 280,147 Cash 2023: € 280,147 ▼ 37% vs 2022 (€ 447,496) Unfavourable step	€ 307,175 Cash 2024: € 307,175 ▲ 10% vs 2023 (€ 280,147) Favourable step	€ 243,946 Cash 2025: € 243,946 ▼ 21% vs 2024 (€ 307,175) Unfavourable step	▼ 21%
Retained profit	€ 36,941 Retained profit 2022: € 36,941 First fiscal year in the series	€ 39,784 Retained profit 2023: € 39,784 ▲ 8% vs 2022 (€ 36,941) Favourable step	€ 42,815 Retained profit 2024: € 42,815 ▲ 8% vs 2023 (€ 39,784) Favourable step	€ 31,088 Retained profit 2025: € 31,088 ▼ 27% vs 2024 (€ 42,815) Unfavourable step	▼ 27%
Dividend	€ 366,000 Dividend 2022: € 366,000 First fiscal year in the series	€ 432,000 Dividend 2023: € 432,000 ▲ 18% vs 2022 (€ 366,000) Unchanged	€ 515,000 Dividend 2024: € 515,000 ▲ 19% vs 2023 (€ 432,000) Unchanged	€ 630,000 Dividend 2025: € 630,000 ▲ 22% vs 2024 (€ 515,000) Unchanged	▲ 22%
Balance sheet total	€ 1,264,132 Balance sheet total 2022: € 1,264,132 First fiscal year in the series	€ 780,381 Balance sheet total 2023: € 780,381 ▼ 38% vs 2022 (€ 1,264,132) Unchanged	€ 1,083,448 Balance sheet total 2024: € 1,083,448 ▲ 39% vs 2023 (€ 780,381) Unchanged	€ 666,700 Balance sheet total 2025: € 666,700 ▼ 38% vs 2024 (€ 1,083,448) Unchanged	▼ 38%
Employees (FTE)	-	-	-	0.2 Employees (FTE) 2025: 0.2 First fiscal year in the series

Key figures of CATALDO MEDICALS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to CATALDO MEDICALS?

What happened at CATALDO MEDICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 30, 2026 New annual accounts for financial year 2025: profit of € 618,272 (▲ 19% vs 2024). Source: NBB ↗
2023 Didier CATALDO became a director. NBB
2023 Anne GODON became a director. NBB
Jan 13, 2004 New establishment in Verviers. KBO
Jan 13, 2004 Start of the company according to the CBE. KBO

In short

From € 369,773 profit in 2022 to € 618,272 profit in 2025.

Paid € 635,229 in corporate taxes since 2022.

Best year ever: 2025, with € 618,272 profit.

Paid out € 1.9 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Didier CATALDO Anne GODON

Fonds Léon Frédéricq pour la Promotion des Recherches médicales, fondamentales et cliniques, auprès du Centre HospitalierUniversitaire de Liège

CMO-IMMO

CATALDO MEDICALS

Behind CATALDO MEDICALS are Didier CATALDO and Anne GODON. The same people are also behind CMO-IMMO. Didier CATALDO is also behind Fonds Léon Frédéricq pour la Promotion des Recherches médicales, fondamentales et cliniques, auprès du Centre HospitalierUniversitaire de Liège.

Directors

According to the 2025 annual accounts

Didier CATALDO

Director

Also active at: Fonds Léon Frédéricq pour la Promotion des Recherches médicales, fondamentales et cliniques, auprès du Centre HospitalierUniversitaire de Liège, CMO-IMMO

since 2023

Anne GODON

Director

Also active at: CMO-IMMO

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin du Vieux Puits 4

4877 Olne

2.342.263.255

Avenue Hanlet 37

4802 Verviers

Active since 13 January 2004

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CMO-IMMO same network

€ 86,687 revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0862.651.484

VAT number

BE 0862.651.484

Registered office

Chemin du Vieux Puits 4, 4877 Olne

Names & denominations

CATALDO MEDICALS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

13 January 2004

Peppol

Active · Active since 28 Dec 2025

Activities · NACE

Activiteiten van huisartspraktijken

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

CATALDO MEDICALS

Financials

What happened to CATALDO MEDICALS?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions